Back to today’s briefing

Story perspectives

Vertex's Cell Therapy Promises Insulin Independence for Diabetes

7/9/2025

24 1

Summary

Story summary

Zimislecel, an innovative cell therapy from Vertex Pharmaceuticals, is making waves in the fight against type I diabetes. In a Phase I/II trial, every patient experienced better blood glucose control, with an impressive 83% achieving insulin independence within a year. With Phase III trials and regulatory submissions on the horizon, hope is rising for a breakthrough in diabetes treatment.

1 of 1

Story summary

Zimislecel, an innovative cell therapy from Vertex Pharmaceuticals, is making waves in the fight against type I diabetes. In a Phase I/II trial, every patient experienced better blood glucose control, with an impressive 83% achieving insulin independence within a year. With Phase III trials and regulatory submissions on the horizon, hope is rising for a breakthrough in diabetes treatment.